BillTracking.org
Back to the feed

Home › US bills › H.R. 1266

United States

H.R. 1266

Combating Illicit Xylazine Act

Judiciary Committee, Energy and Commerce Committee · Rep. Jimmy Panetta (D-CA)

Placed on calendar (Senate) 16 September 2026

Record as of 16 September 2026 — the most recent action in the official record. Status can lag; each step below carries its own date.

  1. 16 September 2026 Placed on calendar (Senate)
  2. 15 September 2026 Passed House with amendment (voice vote)
  3. 4 more actions
    1. 15 September 2026 Motion to reconsider laid on the table Agreed to without objection.
    2. 15 September 2026 DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
    3. 15 September 2026 Considered under suspension of the rules. (consideration: CR H5671-5673)
    4. 15 September 2026 Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  4. 14 September 2026 Reported by committee
  5. 14 September 2026 Placed on calendar (House)
  6. 14 September 2026 Discharged from committee
  7. 5 more actions
    1. 21 July 2026 Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
    2. 21 July 2026 Committee Consideration and Mark-up Session Held
    3. 20 July 2026 Committee Consideration and Mark-up Session Held
    4. 25 June 2026 Forwarded by Subcommittee to Full Committee by Voice Vote.
    5. 25 June 2026 Subcommittee Consideration and Mark-up Session Held
  8. 12 February 2025 Referred to the Subcommittee on Health
  9. 12 February 2025 Referred to committee
  10. 12 February 2025 Introduced in House
This path starts where the bill does — its first action in the official record. Routine procedural steps sit in the “more actions” rows above rather than on the main line.

Read the live feed — on the site or in the app Find it on Congress.gov (opens in a new tab) All US bills